S-4303-119
Read twice and referred to the Committee on Finance.
Sponsored by Tom Cotton (R-AR)
What it does
This bill would impose restrictions or tariffs on electronic nicotine delivery systems (ENDS) — commonly known as vapes or e-cigarettes — manufactured in China. Based on the bill's title and its referral to the Senate Finance Committee, it would likely target Chinese-made vaping products through trade measures such as tariffs, import bans, or other trade restrictions. The full operative text was not provided, so specific mechanisms cannot be confirmed.
Who benefits
U.S.-based vaping product manufacturers and domestic ENDS brands that compete with lower-cost Chinese imports. American tobacco companies with domestic vaping product lines. Workers in U.S. vaping and tobacco manufacturing. Retailers who carry domestically produced ENDS products. Policymakers and public health advocates who argue Chinese-made vapes evade FDA oversight. Non-Chinese foreign ENDS manufacturers who may gain market share.
Who is hurt
U.S. consumers who purchase Chinese-made vaping products, which currently represent a large share of the market, and who may face higher prices or reduced product availability. Small vape retailers dependent on lower-cost Chinese inventory. Chinese ENDS manufacturers and their U.S. importers and distributors. Adult smokers who use vaping products as a cigarette alternative and rely on affordable options. Logistics and import businesses that handle Chinese vaping goods.
Supporters argue
Supporters argue that Chinese-made vaping products — including brands like Elf Bar and Flum — have flooded the U.S. market while evading FDA premarket authorization requirements, exposing consumers, including minors, to unregulated nicotine products. They contend that trade restrictions would level the playing field for compliant domestic manufacturers and reduce the availability of unauthorized products that have been linked to youth vaping rates, which the CDC reported remained elevated among high schoolers in recent years.
Opponents argue
Opponents argue that trade restrictions on Chinese vapes are a blunt instrument that would raise prices for adult consumers who use these products to reduce or replace cigarette smoking, potentially driving them back to more harmful combustible tobacco. They contend that the underlying problem — unauthorized products reaching consumers — is an FDA enforcement failure, not a trade problem, and that tariffs would harm low-income adult vapers disproportionately while doing little to stop smuggled or counterfeit products that would continue to enter the market regardless.